Relationship among VIP plasma levels, esophageal and microcirculatory disorders in systemic sclerosis;Rapporti fra livelli plasmatici di VIP, disfunzione esofagea e del microcircolo in corso di sclerosi sistemica

Minerva Medica

Volumn 91, Issue 9, 2000, Pages 185-189

  Danese, C ^a   Caiola, S ^a   Lucia, P ^a   Cedrone, L ^a   Colotto, M ^a   Arceri, D ^a   Angrisani, L ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Esophageal motility disorders; Scleroderma, systemic; Vasoactive intestinal peptide

Indexed keywords

NEUROTRANSMITTER; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD VESSEL TONE; CAPILLAROSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; ESOPHAGUS FUNCTION DISORDER; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; MANOMETRY; MICROCIRCULATION; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS;

ADULT; AGED; ESOPHAGEAL MOTILITY DISORDERS; ESOPHAGUS; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; SCLERODERMA, SYSTEMIC; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0034491703     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gastrointestinal regulatory peptides in systemic sclerosis
2. Distribution of peptide containing nerve fibres in achalasia of the aesophagus
3. Diagnostic and terapeutic criteria committee. Preliminary criteria for classification of systemic sclerosis (scleroderma)
4. Scleroderma (systemic sclerosis): Classification, subset and pathogenesis
5. Clinical evaluation of systemic sclerosis: A comprehensive panel of diagnostic tests to asses skin, microvascular and visceral involvement
6. Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training
7. Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation: Increase in plasma VIP concentration
8. Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosis
9. Occurrence and distributon of peptidergic nerve fibres in skin biopsies from patients with systemic sclerosis
10. Autonomic nervous system and smooth muscle involvement in systemic sclerosis: Ultrastructural study of 3 cases
11. ET-1 plasma levels during cold stress test in sclerodermic patients
12. Increased plasma adrenomedullin concentrations in patients with Raynaud's phenomenon
13. Studio del bilancio emostatico in corso di sclerosi sistemica
14. Enhanced platelets release reaction and increased thromboxan generation in esophageal achalasia and selective in vitro inibition of arachidonic acid induced aggregation by vasoactive peptide